E
RVNC

Ergoteles’s Revance Therapeutics, Inc. RVNC Stock Holding History

Ergoteles’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,499
Closed -$338K – 1623
2023
Q1 		$338K Sell
10,499
-42,579
-80% -$1.37M 0.01% 860
2022
Q4 		$980K Buy
53,078
+26,369
+99% +$487K 0.04% 468
2022
Q3 		$721K Buy
+26,709
New +$721K 0.03% 625